Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Brian Piekos, officer

Transaction date: April 16, 2026

Reporting date: April 20, 2026

Average share price: -8.578566681859616

Sold 4388.0 shares for 37642.75